Sanara MedTech (SMTI) Competitors $32.24 +0.30 (+0.94%) Closing price 05/1/2025 04:00 PM EasternExtended Trading$31.50 -0.74 (-2.28%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SMTI vs. LQDA, FNA, AORT, MDXG, INMD, EYE, ESTA, AXGN, EMBC, and IRMDShould you be buying Sanara MedTech stock or one of its competitors? The main competitors of Sanara MedTech include Liquidia (LQDA), Paragon 28 (FNA), Artivion (AORT), MiMedx Group (MDXG), InMode (INMD), National Vision (EYE), Establishment Labs (ESTA), AxoGen (AXGN), Embecta (EMBC), and Iradimed (IRMD). These companies are all part of the "medical equipment" industry. Sanara MedTech vs. Liquidia Paragon 28 Artivion MiMedx Group InMode National Vision Establishment Labs AxoGen Embecta Iradimed Liquidia (NASDAQ:LQDA) and Sanara MedTech (NASDAQ:SMTI) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, media sentiment, community ranking, risk, analyst recommendations, earnings and institutional ownership. Is LQDA or SMTI more profitable? Sanara MedTech has a net margin of -10.71% compared to Liquidia's net margin of -765.38%. Sanara MedTech's return on equity of -19.86% beat Liquidia's return on equity.Company Net Margins Return on Equity Return on Assets Liquidia-765.38% -163.21% -67.14% Sanara MedTech -10.71%-19.86%-10.91% Do analysts rate LQDA or SMTI? Liquidia currently has a consensus target price of $26.63, suggesting a potential upside of 90.45%. Sanara MedTech has a consensus target price of $48.50, suggesting a potential upside of 50.43%. Given Liquidia's stronger consensus rating and higher probable upside, equities research analysts plainly believe Liquidia is more favorable than Sanara MedTech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Liquidia 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.11Sanara MedTech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher earnings and valuation, LQDA or SMTI? Sanara MedTech has higher revenue and earnings than Liquidia. Sanara MedTech is trading at a lower price-to-earnings ratio than Liquidia, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLiquidia$14.00M85.20-$78.50M-$1.67-8.37Sanara MedTech$86.67M3.31-$4.30M-$1.14-28.28 Does the MarketBeat Community prefer LQDA or SMTI? Liquidia received 184 more outperform votes than Sanara MedTech when rated by MarketBeat users. Likewise, 68.77% of users gave Liquidia an outperform vote while only 60.53% of users gave Sanara MedTech an outperform vote. CompanyUnderperformOutperformLiquidiaOutperform Votes20768.77% Underperform Votes9431.23% Sanara MedTechOutperform Votes2360.53% Underperform Votes1539.47% Do insiders & institutionals have more ownership in LQDA or SMTI? 64.5% of Liquidia shares are owned by institutional investors. Comparatively, 8.1% of Sanara MedTech shares are owned by institutional investors. 30.1% of Liquidia shares are owned by insiders. Comparatively, 54.1% of Sanara MedTech shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has more risk & volatility, LQDA or SMTI? Liquidia has a beta of 0.23, indicating that its stock price is 77% less volatile than the S&P 500. Comparatively, Sanara MedTech has a beta of 1.47, indicating that its stock price is 47% more volatile than the S&P 500. Does the media refer more to LQDA or SMTI? In the previous week, Liquidia had 7 more articles in the media than Sanara MedTech. MarketBeat recorded 9 mentions for Liquidia and 2 mentions for Sanara MedTech. Sanara MedTech's average media sentiment score of 1.77 beat Liquidia's score of 1.18 indicating that Sanara MedTech is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Liquidia 5 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sanara MedTech 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive SummaryLiquidia beats Sanara MedTech on 10 of the 19 factors compared between the two stocks. Get Sanara MedTech News Delivered to You Automatically Sign up to receive the latest news and ratings for SMTI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMTI vs. The Competition Export to ExcelMetricSanara MedTechSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$286.55M$9.16B$5.54B$7.93BDividend YieldN/A1.64%5.09%4.23%P/E Ratio-32.5719.1622.5718.54Price / Sales3.3169.14399.89103.29Price / CashN/A19.6738.1834.62Price / Book6.185.016.774.25Net Income-$4.30M$284.66M$3.22B$248.18M7 Day Performance1.64%-0.34%1.07%0.91%1 Month Performance7.22%2.93%2.46%2.58%1 Year Performance3.97%-17.64%15.74%4.02% Sanara MedTech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMTISanara MedTech2.0254 of 5 stars$32.24+0.9%$48.50+50.4%+3.2%$286.55M$86.67M-32.5760News CoveragePositive NewsLQDALiquidia2.8559 of 5 stars$14.23+0.8%$26.63+87.1%+6.2%$1.10B$14.00M-8.7350Positive NewsFNAParagon 281.5444 of 5 stars$13.11+0.1%$14.20+8.4%+32.6%$1.10B$256.18M-17.71343,000High Trading VolumeAORTArtivion3.5316 of 5 stars$23.73-0.5%$31.40+32.3%+15.2%$1.01B$388.54M-1,186.501,300Upcoming EarningsNews CoveragePositive NewsMDXGMiMedx Group3.3756 of 5 stars$6.83-1.2%$12.00+75.7%-13.5%$1.01B$348.88M12.42870Earnings ReportAnalyst UpgradePositive NewsINMDInMode3.4022 of 5 stars$14.26-12.1%$20.20+41.7%-14.7%$991.91M$394.82M6.07480Earnings ReportAnalyst ForecastOptions VolumeNews CoverageGap DownHigh Trading VolumeEYENational Vision1.3058 of 5 stars$12.31+0.1%$14.00+13.7%-27.1%$969.82M$1.82B-61.5514,000Upcoming EarningsNews CoveragePositive NewsESTAEstablishment Labs2.7284 of 5 stars$29.57-1.3%$57.40+94.1%-38.7%$852.98M$166.03M-11.46960Upcoming EarningsAXGNAxoGen2.8985 of 5 stars$16.18-1.3%$22.60+39.7%+151.2%$717.49M$187.34M-50.56450Upcoming EarningsPositive NewsEMBCEmbecta4.593 of 5 stars$12.32+3.7%$20.33+65.0%+21.2%$716.21M$1.11B12.321,900Upcoming EarningsNews CoveragePositive NewsIRMDIradimed4.8001 of 5 stars$53.02-0.6%$72.00+35.8%+26.0%$674.15M$73.24M35.35110Positive News Related Companies and Tools Related Companies Liquidia Competitors Paragon 28 Competitors Artivion Competitors MiMedx Group Competitors InMode Competitors National Vision Competitors Establishment Labs Competitors AxoGen Competitors Embecta Competitors Iradimed Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SMTI) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanara MedTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanara MedTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SMTI Stock Free SMTI Stock Alerts